Print Page  Close Window
NASDAQ | VIVO (Common Stock)
01/17/184:00 p.m. ET
$15.250.00 (0.00%)
Stock chart for: VIVO.O.  Currently trading at $15.25 with a 52 week high of $17.20 and a 52 week low of $10.75.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Corporate Profile

Meridian is a fully integrated life science company that develops, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. More

Recent News View More

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 GuidanceRead full article
Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan DiagnosticsRead full article
Meridian Bioscience, Inc. Comments on Preliminary Fiscal 2017 Operating Results and Provides Fiscal 2018 Revenue and Earnings GuidanceRead full article

Events and Presentations View More

View upcoming events as well as all archived events and presentations.

Annual Meeting View More

View information about annual meetings, including reports and proxy statements

Most Viewed Links

News Releases
Events & Presentations
Annual Reports
Stock Quote
Analyst Coverage

Recent News

Events and Presentations

Annual Meetings

View information about annual meetings, including reports and proxy statements
More »

View More »